On Wednesday, Truist Securities updated its financial outlook for The Pennant Group (NASDAQ:PNTG) shares, a healthcare services company, by increasing its price target to $25 from the previous $22. The firm maintained its Hold rating on the stock.
The adjustment comes after considering The Pennant Group's first-quarter results, which have led to an updated earnings forecast for the upcoming years.
Truist Securities now expects The Pennant Group to achieve an adjusted EBITDA of $49.2 million in 2024 and $55.0 million in 2025. These figures are an increase from the previous estimates of $48.2 million for 2024 and $53.8 million for 2025.
Similarly, the adjusted earnings per share (EPS) estimates for The Pennant Group have been revised. For the year 2024, the EPS is now projected to be $0.88, up from the prior estimate of $0.87. For 2025, the EPS forecast has been increased to $1.00 from the earlier prediction of $0.98.
The analyst from Truist Securities stated, "We have adjusted our estimates to reflect 1Q results. We have raised our 2024E and 2025E adjusted EBITDA to $49.2M and $55.0M (vs. prior $48.2M and $53.8M, respectively) and our 2024E and 2025E adjusted EPS to $0.88 and $1.00 (vs. prior $0.87 and $0.98, respectively). We maintain our Hold rating and have raised our price target to $25 (vs. prior $22)."
The updated price target suggests that Truist Securities sees a modest upside potential for The Pennant Group's shares, but the Hold rating indicates that the firm does not recommend adding to positions at this time. The revised financial projections are based on the company's current performance and are not indicative of future market behavior.
InvestingPro Insights
Following the updated financial outlook from Truist Securities for The Pennant Group (NASDAQ:PNTG), recent metrics from InvestingPro shed further light on the company's valuation and performance. The Pennant Group's market capitalization stands at $667.32 million, with a P/E ratio of 40.95, suggesting investors are paying a higher price for each dollar of earnings compared to the industry average, which could be justified by the company's growth prospects. Additionally, the company's revenue has grown by 18.43% over the last twelve months as of Q1 2024, indicating a strong upward trajectory in sales.
Moreover, The Pennant Group's stock price has experienced significant appreciation, with a 3-month total return of 36.68% and a 1-year total return of 82.5%, reflecting robust investor confidence. This performance is aligned with an InvestingPro Tip indicating that net income is expected to grow this year. Another point of interest for investors is the company's PEG ratio of 0.37, which may suggest that the stock could be undervalued relative to its earnings growth.
For investors seeking more comprehensive analysis, there are additional InvestingPro Tips available, including insights on earnings revisions, valuation multiples, and stock price volatility. To explore these further and make informed investment decisions, consider using the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. Visit InvestingPro at https://www.investing.com/pro/PNTG for a total of 14 InvestingPro Tips that could help in assessing The Pennant Group's investment potential.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.